Figure 2From: Soluble Neural-cadherin as a novel biomarker for malignant bone and soft tissue tumors Distrubution of sN-CAD Levels in sarcoma patient s and in control subjects. Boxplot showed sN-CAD levels separately for the major bone sarcomas, soft tissue sarcomas and control subjects.Back to article page